Order Article Reprints

Abdallah ME, El-Readi MZ, Althubiti MA, Almaimani RA, Ismail AM, Idris S, Refaat B, Almalki WH, Babakr AT, Mukhtar MH, et al. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules. 2020; 25(15):3355. https://doi.org/10.3390/molecules25153355

Abdallah, Mohamed E., Mahmoud Zaki El-Readi, Mohammad Ahmad Althubiti, Riyad Adnan Almaimani, Amar Mohamed Ismail, Shakir Idris, Bassem Refaat, Waleed Hassan Almalki, Abdullatif Taha Babakr, Mohammed H. Mukhtar, and et al. 2020. "Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells" Molecules 25, no. 15: 3355. https://doi.org/10.3390/molecules25153355

Abdallah, M. E., El-Readi, M. Z., Althubiti, M. A., Almaimani, R. A., Ismail, A. M., Idris, S., Refaat, B., Almalki, W. H., Babakr, A. T., Mukhtar, M. H., Abdalla, A. N., & Idris, O. F. (2020). Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules, 25(15), 3355. https://doi.org/10.3390/molecules25153355